Taiwan FDA registration f78d6d177de73db9915a7c4888fb02d9
GB HDV Ab
TW: 普生D型肝炎抗體試劑
Taiwan·Risk Class 3·MD·GENERAL BIOLOGICALS CORP.·Registered Dec 12, 2017 – Dec 12, 2027ActiveRegistration details
- Analysis ID
- f78d6d177de73db9915a7c4888fb02d9
- License Form
- Ministry of Health Medical Device Manufacturing No. 005807
Company information
- Manufacturer
- GENERAL BIOLOGICALS CORP.
- Manufacturer Country
- Taiwan, Province of China
- Authorized Representative
- GENERAL BIOLOGICALS CORP.
Product details
- Intended Use
- This product is an external testing reagent, which qualitatively detects human serum or EDTA plasma including IgM and IgG hepatitis D virus antibodies based on the principle of enzyme immunity.
- Product Type (Level 1)
- B Hematology and pathology devices
- Product Type (Level 2)
- B4020 Analyze specific reagents
- Import Information
- Produced in Taiwan, China
Dates and status
- Registration Date
- Dec 12, 2017
- Expiry Date
- Dec 12, 2027
About this record
Access comprehensive regulatory information for GB HDV Ab in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 3 medical device is registered under number f78d6d177de73db9915a7c4888fb02d9 and manufactured by GENERAL BIOLOGICALS CORP.. The authorized representative in Taiwan is GENERAL BIOLOGICALS CORP..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices